KAKEN PHARMACEUTICAL CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,389 JPY | -0.85% |
|
-0.99% | +1.01% |
| Sales 2024 * | 72.7B 467M | Sales 2025 * | 70.2B 451M | Capitalization | 128B 825M |
|---|---|---|---|---|---|
| Net income 2024 * | 7.62B 48.97M | Net income 2025 * | 6.62B 42.55M | EV / Sales 2024 * | 1.77 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.83 x |
| P/E ratio 2024 * |
17.1
x | P/E ratio 2025 * |
19.7
x | Employees | 1,130 |
| Yield 2024 * |
4.43% | Yield 2025 * |
4.43% | Free-Float | 69.31% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.85% | ||
| 1 week | -0.99% | ||
| Current month | -2.02% | ||
| 1 month | -5.63% | ||
| 3 months | -3.09% | ||
| 6 months | +1.65% | ||
| Current year | +1.01% |
1 week
3 389.00
3 464.00
1 month
3 375.003 621.00
Current year
3 326.003 621.00
1 year
3 161.003 890.00
3 years
3 161.005 330.00
5 years
3 161.006 410.00
10 years
3 161.0012 720.00
| Managers | Title | Age | Since |
|---|---|---|---|
| President | 62 | 84-03-31 | |
Tetsuo Onuma
CHM | Chairman | 73 | 74-03-31 |
Masashi Suzudo
BRD | Director/Board Member | 61 | 16-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tetsuo Onuma
CHM | Chairman | 73 | 74-03-31 |
Shoichiro Takagi
BRD | Director/Board Member | 63 | 20-05-31 |
| President | 62 | 84-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.38% | 15 M€ | +5.53% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 3,389 | -0.85% | 120,000 |
| 24-04-24 | 3,418 | -0.61% | 149,100 |
| 24-04-23 | 3,439 | -0.55% | 94,300 |
| 24-04-22 | 3,458 | +1.29% | 125,500 |
| 24-04-19 | 3,414 | -0.26% | 90,200 |
Delayed Quote Japan Exchange, April 25, 2024 at 02:00 am EDT
More quotes
KAKEN PHARMACEUTICAL CO., LTD. is a Japan-based company engaged in the production and sale of pharmaceutical products. The Company operates in two business segments. The Pharmaceutical segment involves in the manufacture and sale of pharmaceuticals, medical devices and agricultural drugs. The Real Estate segment is engaged in the leasing of real estate.
Sector
Pharmaceuticals
Calendar
2024-05-08
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3,389
JPY
Average target price
3,500
JPY
Spread / Average Target
+3.28%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +1.01% | 835M | |
| +24.17% | 562B | |
| -6.33% | 358B | |
| +19.90% | 322B | |
| +7.95% | 297B | |
| +13.45% | 219B | |
| +6.04% | 199B | |
| -10.51% | 196B | |
| -12.26% | 149B | |
| -6.47% | 146B |
- Stock Market
- Equities
- 4521 Stock
